Evaluation of the Effect on Glucose Control and the Safety and Tolerability of AC2993 in Patients With Type 2 Diabetes Mellitus

This study has been completed.

Study NCT00044694 Information provided by Amylin Pharmaceuticals, Inc.

First Received: September 3, 2002 Last Updated: November 5, 2007 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been completed.
Estimated Study Completion Date:	May 2003
Estimated Primary Completion Date:	No date given